<DOC>
	<DOCNO>NCT00945841</DOCNO>
	<brief_summary>This study annual trial registration inactivate split influenza vaccine strain composition season 2009/2010 .</brief_summary>
	<brief_title>Safety Immunogenicity , Inactivated Split Influenza Vaccine , Using Strain Composition 2009/2010</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects eligible enrollment study male female adult 1 . ≥ 18 year age , mentally competent , willing able give inform consent prior study entry 2 . Able comply study requirement 3 . In good health determine : Medical history ; Physical examination ; Clinical judgment investigator . Informed consent must obtain subject enrollment study nature study explain . Subjects enrol study least one follow criterion fulfil : 1 . They serious chronic acute disease ( judgment investigator ) include limited : Cancer , except localize skin cancer ; Advanced congestive heart failure ; Chronic obstructive pulmonary disease ( COPD ) ; Autoimmune disease ( include rheumatoid arthritis ) ; Acute progressive hepatic disease ; Acute progressive renal disease ; Severe neurological psychiatric disorder ; Severe Asthma . 2 . History anaphylactic reaction and/or serious allergic reaction follow vaccination , proven hypersensitivity component study vaccine ( e.g. , ovalbumin , chicken protein , chicken feather , influenza viral protein neomycin polymyxin ) . 3 . Known suspected ( high risk develop ) impairment/alteration immune function ( exclude normally associate advanced age ) result example : Receipt immunosuppressive therapy ( parental oral cortical steroid cancer chemotherapy/radiotherapy ) within past 60 day full length study ; Receipt immunostimulants ; Receipt parenteral immunoglobulin preparation , blood product , and/or plasma derivative within past 3 month full length study . Suspected known HIV infection HIVrelated disease . 4 . Known suspected history drug alcohol abuse . 5 . They bleed diathesis condition associate prolonged bleeding time investigator 's opinion would interfere safety subject ; 6 . Women pregnant woman childbearing potential unwilling practice acceptable contraception duration study ( 21 day ) . Female pregnant nursing ( breastfeed ) mother females childbearing age plan use acceptable birth control measure , duration study . Adequate contraception define hormonal ( oral , injection , transdermal patch , implant , cervical ring ) , barrier ( condom diaphragm ) , intrauterine device ( IUD ) monogamous relationship vasectomize partner vasectomize 6 month prior subject 's study entry . 7 . Influenza vaccination laboratory confirm influenza within last 6 month one influenza vaccination within past 12 month . 8 . Within past 4 week receive : Another vaccine ; Any investigational agent . 9 . Any acute chronic infection require systemic antibiotic treatment antiviral therapy within last 7 day . 10 . They experience fever ( i.e. , axillary temperature ≥ 38°C ) within last 3 day . 11 . Simultaneous participation another clinical study . 12 . Any condition , , opinion investigator , might prevent subject participation interfere evaluation study objective . 13 . Severely obese Body Mass Index ( BMI ) &gt; 35 . 14 . Site personnel involve evaluation safety immediate relative exclude participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>influenza vaccine</keyword>
	<keyword>vaccine</keyword>
</DOC>